WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1992011840) CONTRAST AGENTS FOR MAGNETIC-RESONANCE IMAGING
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1992/011840    International Application No.:    PCT/EP1992/000011
Publication Date: 23.07.1992 International Filing Date: 04.01.1992
Chapter 2 Demand Filed:    25.07.1992    
IPC:
A61K 49/18 (2006.01)
Applicants: BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH [DE/DE]; Byk-Gulden Str. 2, Postfach 100310, D-7750 Konstanz (DE) (For All Designated States Except US).
BELLER, Klaus-Dieter [DE/DE]; (DE) (For US Only).
KOHL, Bernard [DE/DE]; (DE) (For US Only).
LINDER, Rudolf [AT/DE]; (DE) (For US Only)
Inventors: BELLER, Klaus-Dieter; (DE).
KOHL, Bernard; (DE).
LINDER, Rudolf; (DE)
Common
Representative:
BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH; Byk-Gulden-Str. 2, Postfach 100310, D-7750 Konstanz (DE)
Priority Data:
21/91-0 07.01.1991 CH
Title (DE) KONTRASTMITTEL FÜR DIE MR-DIAGNOSTIK
(EN) CONTRAST AGENTS FOR MAGNETIC-RESONANCE IMAGING
(FR) SUBSTANCES DE CONTRASTE POUR LE DIAGNOSTIC RM
Abstract: front page image
(DE)Es werden wäßrige Kontrastmittel für die MR-Diagnostik enthaltend Eisen(III)-tris-(3,4-dihydroxy-2-methyl-5-pyridylmethylphosphat) in Liposomen beschrieben, die oral und invasal angewendet werden können und sich insbesondere zur Diagnose des Abdominalbereichs und der Nieren eignen.
(EN)The aqueous contrast agents described contain iron(III)-tris-(3,4-dihydroxy-2-methyl-5-pyridylmethylphosphate) in liposomes and can be administered both orally and intravenously. They are particularly suitable for examining the abdomenal region and the kidneys.
(FR)On décrit des substances aqueuses de contraste pour le diagnostic RM, contenant du fer(III)-tris-(3,4-dihydroxy-2-méthyl-5-pyridylméthylphosphate) dans des liposomes, lesquelles peuvent être appliquées par voie orale et intravasculaire et lesquelles conviennent en particulier au diagnostic de la zone abdominale et des reins.
Designated States: AU, CA, CS, DE, FI, HU, JP, KR, NO, PL, RU, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, MC, NL, SE).
Publication Language: German (DE)
Filing Language: German (DE)